Preparation of 5-heteroaryl thiazoles and their use as phosphoinositide 3-kinase (PI3K) inhibitors
Bradley Shaw2017-11-07T15:58:41+00:001. Preparation of 5-heteroaryl thiazoles and their use as phosphoinositide 3-kinase (PI3K) inhibitors Bengtsson,
Preparation of thiazole derivatives as antitumor agents
Bradley Shaw2017-11-07T15:58:12+00:002. Preparation of thiazole derivatives as antitumor agents Arnould, Jean-Claude; Foote, Kevin Michael; Griffen,
Indole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as inhibitors of PI3K and /or mTOR kinase
Bradley Shaw2017-11-07T15:57:48+00:003. Indole derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use
Pyrimidine derivatives as antiproliferative agents and their preparation, pharmaceutical compositions and use in the treatment of diseases
Bradley Shaw2017-11-07T15:57:16+00:004. Pyrimidine derivatives as antiproliferative agents and their preparation, pharmaceutical compositions and use in
Preparation of pyrimidine derivatives having inhibitory activity against PI3K enzymes
Bradley Shaw2017-11-07T15:56:53+00:005. Preparation of pyrimidine derivatives having inhibitory activity against PI3K enzymes Butterworth, Sam; Griffen,
Preparation of pyrimidine derivatives having inhibitory activity against PI3K enzymes
Bradley Shaw2017-11-07T15:56:33+00:006. Preparation of pyrimidine derivatives having inhibitory activity against PI3K enzymes Butterworth, Sam; Griffen,
Preparation of pyrimidine derivatives for treating proliferative disorders sensitive to inhibition of PI3K and/or mTOR kinase.
Bradley Shaw2017-11-07T15:56:10+00:007. Preparation of pyrimidine derivatives for treating proliferative disorders sensitive to inhibition of PI3K
Preparation of 6-benzimidazolyl-2-morpholino-4-(azetidine, pyrrolidine, piperidine, or azepine) pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorders
Bradley Shaw2017-11-07T15:55:46+00:008. Preparation of 6-benzimidazolyl-2-morpholino-4-(azetidine, pyrrolidine, piperidine, or azepine) pyrimidine derivatives as PI3K and mTOR
Preparation of 4-benzimidazolyl-6-morpholino-2-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder
Bradley Shaw2017-11-07T15:55:14+00:009. Preparation of 4-benzimidazolyl-6-morpholino-2-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment
Preparation of 4-benzimidazolyl-6-morpholino-2-piperazinyl-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder
Bradley Shaw2017-11-07T15:54:42+00:0010. Preparation of 4-benzimidazolyl-6-morpholino-2-piperazinyl-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment
